Lack of effect of γ-hydroxybutyrate on μ, δ and κ opioid receptor binding

Neuroscience Letters

Volumn 212, Issue 1, 1996, Pages 5-8

  Feigenbaum, Jeffery J ^a   Simantov, Rabi ^b  

^a American Institute of Biotechnology   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Neuroblastoma x glioma hybrid cells; Receptor binding; Hydroxybutyrate; , and Opioid receptor

Indexed keywords

4 HYDROXYBUTYRIC ACID; DELTA OPIATE RECEPTOR; DIPRENORPHINE; DYNORPHIN; ENKEPHALIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ETORPHINE; KAPPA OPIATE RECEPTOR; LEVALLORPHAN; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; OPIATE AGONIST; OPIATE ANTAGONIST;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; EMBRYO; GLIOMA; GUINEA PIG; HYBRID CELL; NERVE CELL CULTURE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030570407     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12786-5     Document Type: Article

References (37)

1. [1] Ahtee, L., Attila, L. and Carlson, K.R., Augmentation of morphine-induced changes in brain monoamine metabolism after chronic naltrexone treatment, J. Pharmacol. Exp. Ther., 255 (1990) 803-808.
2. [2] Allan, E.H., Green, I.C. and Titheradge, M.A., The stimulation of glycogenolysis and gluconeogenesis in isolated hepatocytes by opioid peptides, Biochem. J., 216 (1983) 507-510.
3. [3] Boyd, A.J., Sherman, I.A., Saibil, F. and Mamelak, M., The protective effect of γ-hydroxybutyrate in regional intestinal ischemia in the hamster, Gastroenterology, 99 (1990) 860-862.
4. [4] Crosby, G., Ito, M., Kaufman, E., Nelson, T. and Sokoloff, L., Naloxone pretreatment alters the local cerebral metabolic effect of gammahydroxybutyrate in rats, Brain Res., 275 (1983) 194-197.
5. [5] Doherty, J.D., Hattox, S., Snead, O.C. and Roth, R.H., Identification of endogenous γ-hydroxybutyrate in human and bovine brain and its regional distribution in human, guinea pig and rhesus monkey brain, J. Pharmacol. Exp. Ther., 207 (1978) 130-139.
6. [6] Dudek, B.C. and Fanelli, R.J., Effects of γ-butryolactone, amphetamine and haloperidol in mice differing in sensitivity to alcohol, Psychopharmacology, 68 (1980) 89-97.
7. [7] Dyck, L.E. and Kazahoff, C.W., Acceleration of the biosynthesis of rat striatal dopamine by incubation and by administration of gamma butyrolactone, J. Neurosci. Res., 8 (1982) 57-65.
8. [8] Ellinwood, E.H., Gonzalez, A.E. and Dougherty, G.G., γ-Butyrolactone effects on behavior induced by dopamine agonists, Biol. Psychiatry, 18 (1983) 1023-1032
9. [9] Feigenbaum, J.J., Yanai, J. and Moon, B.H., Differential catecholamine uptake inhibition as a possible mode of action of d-amphetamine induced locomotor activity, Res. Commun. Chem. Path. Pharmacol., 39 (1983) 349-352.
10. [10] Feigenbaum, J.J., Fishman, R.H.B. and Yanai, J., Mechanisms of dopamine antagonism by morphine, Subst. Alcohol Actions/Misuse, 3 (1982) 307-324.
11. [11] Friederich, M.W., Friederich, D.P. and Walker, J.M., Effects of dynorphin(1-8) on movement: non-opiate effects and structure-activity relationships, Peptides, 8 (1987) 837-840.
12. [12] Gobaille, S., Schmidt, C., Cupo, A., Herbrecht, F. and Maitre, M., Characterization of methionine enkephalin release in the rat striatum by in vivo dialysis: effects of gamma-hydroxybutyrate on cellular and extracellular methionine-enkephalin levels, Neuroscience, 60 (1994) 637-648.
13. [13] Godschalk, M., Dzoljic, M. and Bonta, I.L., Slow wave sleep and a state resembling absence catalepsy induced in the rat by γ-hydroxybutyrate, Eur. J. Pharmacol., 44 (1977) 105-111.
14. [14] Hechler, V., Gobaille, S., Bourguignon, J.-J. and Maitre, M., Extracellular events induced by γ-hydroxybutyrate in striatum: a microdialysis study, J. Neurochem., 56 (1991) 938-944.
15. [15] Hechler, V., Peter, P., Gobaille, S., Bourguignon, J.-J., Schmitt, M., Ehrhardt, J.-D., Mark, J. and Maitre, M., γ-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities, J. Pharmacol. Exp. Ther., 264 (1993) 1406-1414.
16. [16] Hedner, J., Jonason, J. and Lundberg, D., Respiratory effects of γ-hydroxybutyric acid in anaesthetized rats, J. Neural Transm., 49 (1980) 179-186.
17. 2-dynorphin-(1-11) in rats, Life Sci., 27 (1980) 883-892.
18. [18] Kuschinsky, K. and Hornykiewicz, O., Morphine catalepsy in the rat: relation to striatal dopamine metabolism, Eur. J. Pharmacol., 19 (1972) 119-122.
19. [19] Jolicoeur, F.B., Menard, D., Rivest, R., Lemaire, S. and Belleau, B., Neurobehavioral evidence for kappa agonist activity of the morphinan derivative 14-β-methyl 8 oxacyclorphan, Pharmacol. Biochem. Behav., 38 (1991) 401-405.
20. [20] Lason, W., Przewocka, B. and Przewocki, R., The effect of γ-hydroxybutyrate and anticonvulsants on opioid peptide content in the rat brain, Life Sci., 33 (suppl. 1) (1983) 599-602.
21. [21] Maitre, M., Hechler, V., Vayer, P., Gobaille, S., Cash, C.D., Schmitt, M. and Bourguignon, J.-J., A specific γ-hydroxybutyrate receptor ligand possesses antagonistic and anti-convulsant properties, J. Pharmacol. Exp. Ther., 255 (1990) 657-663.
22. [22] Mamelak, M., Gammahydroxybutyrate: an endogenous regulator of energy metabolism, Neurosci. Behav. Rev., 13 (1989) 187-198.
23. [23] Menon, K., Bieger, D., and Hornykiewicz, O., Pharmacological evidence for a selective antidopaminergic action of gamma-hydroxybutyric acid, J. Neural Transm., 39 (1973) 177-186.
24. [24] Moroni, F., Cheney, D.L. and Costa, E., The turnover rate of acetylcholine in brain nuclei of rats injected intraventricularly and intraseptally with alpha and beta-endorphin, Neuropharmacology, 17 (1978) 191-196.
25. [25] Olianas, M.C., Synergistic potentiation of haloperidol-induced catalepsy by γ-butyrolactone, J. Neurochem., 27 (1976) 821-823.
26. [26] Roth, R.H., Doherty, J.D. and Walters, J.R., Gamma-hydroxybutyrate: a role in the regulation of dopaminergic neurons? Brain Res., 189 (1980) 556-560.
27. [27] Roth, R.H. and Giarman, N.J., Natural occurrence of gamma-hydroxybutyrate in mammalian brain, Biochem. Pharmacol., 19 (1970) 1087-1094.
28. [28] Roth, R.H. and Suhr, Y., Mechanism of gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to 'sleep', Biochem. Pharmacol., 19 (1970) 3001-3010.
29. 3H]-dopamine in the striatum: an adaptation of the push-pull cannula method to awake restrained and anesthestized rats, Brain Res. Bull., 16 (1986) 149-154.
30. [30] Sethy, V.H., Roth, R.H., Walters, J.R., Marini, J. and Van Woert, M.H., Effect of anaesthetic doses of γ-hydroxybutyrate on the acetylcholine content of rat brain, Naunyn-Schmiedeberg's Arch. Pharmacol., 295 (1976) 9-14.
31. [31] Sherman, A.D. and Gebhart, G.F., An evaluation of the analgesia induced by morphine and gamma-hydroxybutyrate, Arch. Int. Pharmacodyn. Ther., 213 (1975), 195-199.
32. [32] Snead, O.C. and Bearden, L.J., Naloxone overcomes the dopaminergic, EEG, and behavioral effects of γ-hydroxybutyrate, Neurology, 30 (1980) 832-838.
33. [33] Trijillo, K.A., Day, R. and Akil, H., Effect of amphetamine on dynorphin A(1-8), dynorphin A(1-16), α-neo-endorphin and β-neo-endorphin, Brain Res., 518 (1990) 244-256.
34. [34] Vayer, P and Maitre, M., γ-Hydroxybutyrate stimulation of the formation of cyclic GMP and inositol phosphates in rat hippocampal slices, J. Neurochem., 52 (1989) 1382-1387.
35. [35] Veyer, P., Mandel, P. and Maitre, M., γ-Hydroxybutyrate: a possible neurotransmitter, Life Sci., 41 (1987) 1547-1557.
36. [36] Walker, J.M., Moises, H.C., Coy, D.H., Baldrighi, G. and Akil, H., Nonopiate effects of dynorphin and des-Tyr-dynorphin, Science, 218 (1982) 1136-1138.
37. [37] Wolfson, L.I., Sakurada, O. and Sokoloff, L, Effects of γ-butyrolactone on local cerebral glucose utilization in the rat, J. Neurochem., 29 (1977) 777-783.